121 related articles for article (PubMed ID: 6334231)
1. Dependence of T-cell-replacing factor and immunogenic dose for the production of monoclonal antibodies using the in vitro immunization technique.
Borrebaeck CA
Mol Immunol; 1984 Oct; 21(10):841-5. PubMed ID: 6334231
[TBL] [Abstract][Full Text] [Related]
2. In vitro immunization. Effect of growth and differentiation factors on antigen-specific B cell activation and production of monoclonal antibodies to autologous antigens and weak immunogens.
Borrebaeck CA; Möller SA
J Immunol; 1986 May; 136(10):3710-5. PubMed ID: 3486221
[TBL] [Abstract][Full Text] [Related]
3. In vitro immunization for the production of antigen-specific lymphocyte hybridomas.
Borrebaeck CA
Scand J Immunol; 1983 Jul; 18(1):9-12. PubMed ID: 6192490
[TBL] [Abstract][Full Text] [Related]
4. Influence of antigen presentation and exogenous cytokine activity during in vitro primary immunizations employed for the generation of monoclonal antibodies.
Halabi G; McCullough KC
J Immunol Methods; 1995 Oct; 186(2):205-16. PubMed ID: 7594620
[TBL] [Abstract][Full Text] [Related]
5. Increased proportion of antigen-specific antibody-producing hybridomas following an in vitro immunization with in vivo immunized mouse spleen cells.
Enriquez FJ; Bradley-Dunlop D; Joens L
Hybridoma; 1991 Dec; 10(6):745-51. PubMed ID: 1816073
[TBL] [Abstract][Full Text] [Related]
6. In vitro B-lymphocyte antigen priming against both non-immunogenic and immunogenic molecules requiring low amounts of antigen and applicable in hybridoma technology.
Brams P; Pettijohn DE; Brown M; Olsson L
J Immunol Methods; 1987 Apr; 98(1):11-22. PubMed ID: 2435806
[TBL] [Abstract][Full Text] [Related]
7. Production of monoclonal antibodies with preselected submolecular binding specificities to protein antigenic sites: antibodies to sperm whale myoglobin sites.
Schmitz HE; Atassi H; Atassi MZ
Mol Immunol; 1983 Jul; 20(7):719-26. PubMed ID: 6193418
[TBL] [Abstract][Full Text] [Related]
8. Intrasplenic primary immunization for the production of monoclonal antibodies.
Spitz M; Spitz L; Thorpe R; Eugui E
J Immunol Methods; 1984 May; 70(1):39-43. PubMed ID: 6609209
[TBL] [Abstract][Full Text] [Related]
9. Production of monoclonal antibodies specific for African swine fever virus following in vitro primary immunization of mouse splenocytes in the presence of stimulated T lymphocyte supernatants.
Federspiel G; McCullough KC; Kihm U
J Immunol Methods; 1991 Dec; 145(1-2):71-81. PubMed ID: 1765668
[TBL] [Abstract][Full Text] [Related]
10. In vitro immunization of mouse spleen cells for the production of monoclonal IgG1 antibodies using an antigen-specific T helper cell clone (D.10.G4.1).
Uthoff S; Böldicke T
J Immunol Methods; 1993 Dec; 166(2):165-75. PubMed ID: 7507145
[TBL] [Abstract][Full Text] [Related]
11. Requirements for the generation of memory B cells in vivo and their subsequent activation in vitro for the production of antigen-specific hybridomas.
De Boer M; Ten Voorde GH; Ossendorp FA; Van Duijn G; Tager JM
J Immunol Methods; 1988 Oct; 113(1):143-9. PubMed ID: 2459251
[TBL] [Abstract][Full Text] [Related]
12. Production of IgG-producing hybridomas by in vitro stimulation of murine spleen cells.
Takahashi M; Fuller SA; Hurrell JG
J Immunol Methods; 1987 Feb; 96(2):247-53. PubMed ID: 3492563
[TBL] [Abstract][Full Text] [Related]
13. Obligatory role of gamma interferon in T cell-replacing factor-dependent, antigen-specific murine B cell responses.
Brunswick M; Lake P
J Exp Med; 1985 May; 161(5):953-71. PubMed ID: 2580939
[TBL] [Abstract][Full Text] [Related]
14. Production of monoclonal antibodies to thyroglobulin by in vitro immunization with a free synthetic peptide.
de Boer M; Ossendorp FA; Al BJ; Hilgers J; de Vijlder JJ; Tager JM
Mol Immunol; 1987 Oct; 24(10):1081-6. PubMed ID: 3683404
[TBL] [Abstract][Full Text] [Related]
15. [The production of hybridomas producing monoclonal antibodies to the causative agent of melioidosis by using antigen-stimulated lymphocytes in an in-vitro system].
Titova NG; Razina IV; Sviridov VV; Iakovleva IV; Khrapova NP; Kulakov MIa
Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):82-3. PubMed ID: 8553782
[No Abstract] [Full Text] [Related]
16. BCGFII activity on activated B cells of a purified murine T cell-replacing factor (TRF) from a T cell hybridoma (B151K12).
Harada N; Kikuchi Y; Tominaga A; Takaki S; Takatsu K
J Immunol; 1985 Jun; 134(6):3944-51. PubMed ID: 3872907
[TBL] [Abstract][Full Text] [Related]
17. Mimicking the humoral immune response in vitro results in antigen-specific isotype switching supported by specific autologous T helper cells: generation of human HIV-1-neutralizing IgG monoclonal antibodies from naive donors.
Chin LT; Malmborg AC; Kristensson K; Hinkula J; Wahren B; Borrebaeck CA
Eur J Immunol; 1995 Mar; 25(3):657-63. PubMed ID: 7535699
[TBL] [Abstract][Full Text] [Related]
18. High frequency production of hybridomas secreting antibodies to cell antigens.
Cianfriglia M; Nuti M; Turchi V; Barca S; Tombesi M; Morrone S; Cenciarelli C; Natali PG
Hybridoma; 1987 Dec; 6(6):673-7. PubMed ID: 3501765
[TBL] [Abstract][Full Text] [Related]
19. Use of I region-restricted, antigen-specific T cell hybridomas to produce idiotypically specific anti-receptor antibodies.
White J; Haskins KM; Marrack P; Kappler J
J Immunol; 1983 Mar; 130(3):1033-7. PubMed ID: 6185566
[TBL] [Abstract][Full Text] [Related]
20. Selective elimination of a B cell subset having acceptor site(s) for T cell-replacing factor (TRF) with biotinylated antibody to the acceptor site(s) and avidin-ricin A-chain conjugate.
Hashimoto N; Takatsu K; Masuho Y; Kishida K; Hara T; Hamaoka T
J Immunol; 1984 Jan; 132(1):129-35. PubMed ID: 6418795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
